Back to search
FDAFDA · Food and drugs·Recall number Z-2290-2021

Trilogy Evo Universal, Product number DS2000X11B

Published August 25, 2021 · Recall initiated: July 26, 2021

Summary

FDA records medical device Class II recall Z-2290-2021, published August 25, 2021 and initiated July 26, 2021. Recalling firm: Philips Respironics, Inc.; Status: Ongoing; Reported quantity: 10,000 (FEMA Stockpile Only); Lot: Software version numbers 1.02.01.00, 1.03.05.00, 1.03.07.00, 1.04.02.00, 1.04.06, 1.05.01, and 1.06.02. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Two software issues have been identified related to pressure increase in the device: The first issue is described as "Infant/Pediatric EFS Calibration Pressure Increase" and the second issue is described as "Pressure Drift (Continuous Usage).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Philips Respironics, Inc.
Distributor
Worldwide distribution - US nationwide distribution.
Lot
Software version numbers 1.02.01.00, 1.03.05.00, 1.03.07.00, 1.04.02.00, 1.04.06, 1.05.01, and 1.06.02
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Trilogy Evo Universal, Product number DS2000X11B recalled?

Yes. FDA published recall Z-2290-2021 on August 25, 2021. Reported hazard: Two software issues have been identified related to pressure increase in the device: The first issue is described as "Infant/Pediatric EFS Calibration Pressure Increase" and the second issue is described as "Pressure Drift (Continuous Usage).

What should I do if I have this product?

Voluntary: Firm initiated · Letter